These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 3313791

  • 1. [Controlled study of a new anti-allergic agent, N-acetyl-aspartyl- glutamic acid (NAAGA), in the local treatment of pollinosis].
    Girard JP, Weibel MA.
    Ther Umsch; 1987 Aug; 44(8):607-11. PubMed ID: 3313791
    [No Abstract] [Full Text] [Related]

  • 2. [NAAGA and cromoglycate. A comparison in the treatment of seasonal allergic rhinitis].
    Datz B, Sieger C, Weibel MA.
    Laryngol Rhinol Otol (Stuttg); 1988 Jun; 67(6):300-3. PubMed ID: 3136279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nasal application of a gel formulation of N-acetyl-aspartyl glutamic acid (NAAGA) compared with placebo and disodium cromoglycate in the symptomatic treatment of pollinosis.
    Althaus MA, Pichler WJ.
    Allergy; 1994 Mar; 49(3):184-8. PubMed ID: 7911011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the efficacy of the magnesium salt of N-acetyl-aspartyl-glutamic acid in the treatment of acute rhinitis].
    Miadonna A, Tedeschi A, Parravicini P, Lorini M.
    Clin Ter; 1989 Nov 15; 131(3):173-6. PubMed ID: 2575479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effectiveness and tolerance of the C3 convertase inhibitor, N-acetyl-aspartyl-magnesium glutamate in perennial rhinitis. Results of a double-blind, placebo-controlled study].
    Harnest U, Kiehn R, Sieger C, Weibel MA.
    Arzneimittelforschung; 1989 Feb 15; 39(2):273-5. PubMed ID: 2659003
    [Abstract] [Full Text] [Related]

  • 9. N-acetyl-aspartyl-glutamic acid inhibits cellular recruitment and mediator release during the late allergen-induced nasal reaction.
    Miadonna A, Milazzo N, Salmaso C, Cottini M, Lorini M, Tedeschi A.
    Eur J Clin Pharmacol; 1998 Sep 15; 54(7):515-20. PubMed ID: 9832292
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness and tolerance of the C3 convertase inhibitor, N-acetyl-aspartyl-magnesium glutamate with anti-allergic action. Results of a double-blind study].
    Gastpar H, Kiehn R, Sieger C, Weibel MA.
    Arzneimittelforschung; 1989 Feb 15; 39(2):270-2. PubMed ID: 2659002
    [Abstract] [Full Text] [Related]

  • 11. Topical treatment of seasonal allergic rhinitis with a beta-adrenoceptor stimulant (KWD 2131).
    Svensson G.
    Rhinology; 1982 Sep 15; 20(3):159-66. PubMed ID: 6127780
    [Abstract] [Full Text] [Related]

  • 12. [NAAGA versus disodium cromoglycate in perennial allergic rhinopathy: results of a multicenter study].
    Gastpar H, Kiehn R, Sieger C, Weibel MA.
    Schweiz Rundsch Med Prax; 1989 May 16; 78(20):585-8. PubMed ID: 2500692
    [Abstract] [Full Text] [Related]

  • 13. A comparison of an aqueous and a pressurized nasal spray of beclomethasone dipropionate in the management of seasonal rhinitis.
    Harries MG, Anderson PB, Gibson GJ, Hof ZE, Baggott PJ.
    Pharmatherapeutica; 1984 May 16; 3(9):623-5. PubMed ID: 6374683
    [Abstract] [Full Text] [Related]

  • 14. N-acetyl-aspartyl glutamic acid (NAAGA) topical eyedrops in the treatment of giant papillary conjunctivitis (GPC).
    Meijer F, Pogany K, Kok JH, Kijlstra A.
    Doc Ophthalmol; 1993 May 16; 85(1):5-11. PubMed ID: 7910133
    [Abstract] [Full Text] [Related]

  • 15. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May 16; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 16. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M.
    Br J Ophthalmol; 1998 Oct 16; 82(10):1135-8. PubMed ID: 9924299
    [Abstract] [Full Text] [Related]

  • 17. Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis.
    Chandra RK, Heresi G, Woodford G.
    Ann Allergy; 1982 Sep 16; 49(3):131-4. PubMed ID: 6126145
    [Abstract] [Full Text] [Related]

  • 18. Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber.
    Yamamoto H, Yonekura S, Sakurai D, Katada K, Inamine A, Hanazawa T, Horiguchi S, Okamoto Y.
    Allergy Asthma Proc; 2012 Sep 16; 33(5):397-403. PubMed ID: 23026181
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun 16; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 20. Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis.
    Nuutinen J, Ruoppi P, Sorri M, Suonpää J, Vainio-Mattila J.
    Rhinology; 1983 Jun 16; 21(2):165-72. PubMed ID: 6351231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.